Baidu
map

消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2016 胃癌HER2检测指南（2016版）

2016-08-15 中国肿瘤科相关专家小组（统称） 中华病理学杂志,2016,45(08): 528-532.

胃癌HER2检测

胃癌HER2检测指南(2016版)专家组通过总结我国近年来胃癌HER2检测现状和实践经验，结合国内外近年来在胃癌HER2领域的研究进展，对2011版《胃癌HER2检测指南》的内容进行了补充和更新，制定了《胃癌HER2检测指南(2016版)》，供国内开展胃癌诊疗的单位和进行胃癌HER2检测的实验室参考。

中文标题：

2016 胃癌HER2检测指南（2016版）

发布机构：

中国肿瘤科相关专家小组（统称）

发布日期：

2016-08-15

简要介绍：

2011版《胃癌HER2检测指南》发布已经5年，5年来随着胃癌临床诊治的发展，国内胃癌HER2检测率显著提高，检测质量也明显改善，HER2检测质量保证的重要性也得到了临床和病理人员的广泛认识。但与此同时，HER2检测实践中的一些问题也不断显现，例如胃镜活检标本HER2检测未得到普及；原位杂交检测率低下，并由此导致大多数免疫组织化学染色(IHC)2＋的胃癌病例未能最终明确HER2状态；部分单位HER2阳性率与国内外文献报道差异较大。此外，随着全球范围内胃癌HER2研究数据以及抗HER2靶向治疗经验的积累，人们对HER2在胃癌诊疗中的意义有了更深刻的认识，也对胃癌HER2检测有了更高的要求。胃癌HER2检测指南(2016版)专家组通过总结我国近年来胃癌HER2检测现状和实践经验，结合国内外近年来在胃癌HER2领域的研究进展，对2011版《胃癌HER2检测指南》的内容进行了补充和更新，制定了《胃癌HER2检测指南(2016版)》，供国内开展胃癌诊疗的单位和进行胃癌HER2检测的实验室参考。


制定者： 
《胃癌HER2检测指南(2016版)》专家组 
中国肿瘤科相关专家小组（统称）

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 胃癌HER2检测指南（2016版）)] GetToolGuiderByIdResponse(projectId=1, id=c90de1c00125a9b1, title=2016 胃癌HER2检测指南（2016版）, enTitle=, guiderFrom=中华病理学杂志,2016,45(08): 528-532., authorId=null, author=, summary=胃癌HER2检测指南(2016版)专家组通过总结我国近年来胃癌HER2检测现状和实践经验，结合国内外近年来在胃癌HER2领域的研究进展，对2011版《胃癌HER2检测指南》的内容进行了补充和更新，制定了《胃癌HER2检测指南(2016版)》，供国内开展胃癌诊疗的单位和进行胃癌HER2检测的实验室参考。, cover=, journalId=null, articlesId=null, associationId=747, associationName=中国肿瘤科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Mon Aug 15 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2011版《胃癌HER2检测指南》发布已经5年，5年来随着胃癌临床诊治的发展，国内胃癌HER2检测率显著提高，检测质量也明显改善，HER2检测质量保证的重要性也得到了临床和病理人员的广泛认识。但与此同时，HER2检测实践中的一些问题也不断显现，例如胃镜活检标本HER2检测未得到普及；原位杂交检测率低下，并由此导致大多数免疫组织化学染色(IHC)2＋的胃癌病例未能最终明确HER2状态；部分单位HER2阳性率与国内外文献报道差异较大。此外，随着全球范围内胃癌HER2研究数据以及抗HER2靶向治疗经验的积累，人们对HER2在胃癌诊疗中的意义有了更深刻的认识，也对胃癌HER2检测有了更高的要求。胃癌HER2检测指南(2016版)专家组通过总结我国近年来胃癌HER2检测现状和实践经验，结合国内外近年来在胃癌HER2领域的研究进展，对2011版《胃癌HER2检测指南》的内容进行了补充和更新，制定了《胃癌HER2检测指南(2016版)》，供国内开展胃癌诊疗的单位和进行胃癌HER2检测的实验室参考。 <div><br> </div> <div><span style="font-weight: bold;">制定者：</span> </div> <div>《胃癌HER2检测指南(2016版)》专家组 </div> <div>中国肿瘤科相关专家小组（统称）</div> <div><br> 拓展指南：<strong>与<font color="red">胃癌</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=5b0f11c001253e80" title="2016NCCN临床实践指南：胃癌（2016.V3）" target="_blank">2016NCCN临床实践指南：胃癌（2016.V3）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=386331c00123a0f9" title="2016 NCCN临床实践指南：胃癌（2016.V2）" target="_blank">2016 NCCN临床实践指南：胃癌（2016.V2）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=c68621c0012260aa" title="2014 日本胃癌治疗指南（第四版）" target="_blank">2014 日本胃癌治疗指南（第四版）</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=acd071c0012199cd" title="2015 ASGE指南：内镜在胃癌前病变和恶性肿瘤管理中的作用" target="_blank">2015 ASGE指南：内镜在胃癌前病变和恶性肿瘤管理中的作用</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=137801c0011598a5" title="NCCN临床实践指南：胃癌（2016.V1）" target="_blank">NCCN临床实践指南：胃癌（2016.V1）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E8%83%83%E7%99%8C" target="_blank">有关胃癌更多指南</a></ul></div>, tagList=[TagDto(tagId=438, tagName=胃癌), TagDto(tagId=34499, tagName=HER2检测)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=69, categoryName=检验, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=15518, appHits=419, showAppHits=5, pcHits=10316, showPcHits=6922, likes=165, shares=20, comments=9, approvalStatus=1, publishedTime=Tue Aug 16 10:37:55 CST 2016, publishedTimeString=2016-08-15, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Tue Aug 16 10:37:55 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 20:40:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 胃癌HER2检测指南（2016版）)])
2016 胃癌HER2检测指南（2016版）
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=106641, encodeId=4e0f1066417c, content=总结和总结，新理念，值得重视！值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:57:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106643, encodeId=b75210664327, content=新理念，值得重视！值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:57:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105256, encodeId=42dd105256e7, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:35:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105172, encodeId=4e751051e299, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:00:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101866, encodeId=df0d101866aa, content=值得学习，继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=424a1684197, createdName=摩天轮, createdTime=Sun Aug 21 08:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=)]
    2016-08-29 zibozhouping

    总结和总结，新理念，值得重视！值得学习。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=106641, encodeId=4e0f1066417c, content=总结和总结，新理念，值得重视！值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:57:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106643, encodeId=b75210664327, content=新理念，值得重视！值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:57:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105256, encodeId=42dd105256e7, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:35:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105172, encodeId=4e751051e299, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:00:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101866, encodeId=df0d101866aa, content=值得学习，继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=424a1684197, createdName=摩天轮, createdTime=Sun Aug 21 08:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=)]
    2016-08-29 zibozhouping

    新理念，值得重视！值得学习。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=106641, encodeId=4e0f1066417c, content=总结和总结，新理念，值得重视！值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:57:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106643, encodeId=b75210664327, content=新理念，值得重视！值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:57:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105256, encodeId=42dd105256e7, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:35:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105172, encodeId=4e751051e299, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:00:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101866, encodeId=df0d101866aa, content=值得学习，继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=424a1684197, createdName=摩天轮, createdTime=Sun Aug 21 08:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=)]
    2016-08-27 zibozhouping

    先下手为强?，学习学习，参考相关知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=106641, encodeId=4e0f1066417c, content=总结和总结，新理念，值得重视！值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:57:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106643, encodeId=b75210664327, content=新理念，值得重视！值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:57:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105256, encodeId=42dd105256e7, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:35:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105172, encodeId=4e751051e299, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:00:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101866, encodeId=df0d101866aa, content=值得学习，继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=424a1684197, createdName=摩天轮, createdTime=Sun Aug 21 08:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=)]
    2016-08-27 1e0f7307m29(暂无匿称)

    实用，特别实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=106641, encodeId=4e0f1066417c, content=总结和总结，新理念，值得重视！值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:57:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=106643, encodeId=b75210664327, content=新理念，值得重视！值得学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Mon Aug 29 07:57:00 CST 2016, time=2016-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105256, encodeId=42dd105256e7, content=先下手为强?，学习学习，参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:35:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105172, encodeId=4e751051e299, content=实用，特别实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Sat Aug 27 00:00:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101866, encodeId=df0d101866aa, content=值得学习，继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=424a1684197, createdName=摩天轮, createdTime=Sun Aug 21 08:18:00 CST 2016, time=2016-08-21, status=1, ipAttribution=)]
    2016-08-21 摩天轮

    值得学习，继续关注

    0

相关指南

2014 日本胃癌治疗指南（第四版）

日本胃癌学会(JGCA,Japanese Gastric Cancer Association) · 2016-06-24

胃癌手术消化道重建机械吻合专家共识

暂未更新 · 2015-06-02

胃癌相关标志物免疫组化指标选择专家共识( 2014)

中国肿瘤科相关专家小组（统称） · 2014-09-28

中国早期胃癌筛查及内镜诊治共识意见（2014年，长沙）

中华医学会内镜学分会(CSDE,Chinese Society of Digestive Endoscopy) · 2014-07-12

Baidu
map
Baidu
map
Baidu
map